Titled “The Addicted Brain and New Treatment Frontiers”, the event is being presented by: The Aspen Brain Forum Foundation, Science Translational Medicine, and the New York Academy of Sciences. NCADD is supporting the Conference.
The event will be held at The New York Academy of Sciences, 7 World Trade Center (250 Greenwich Street), 40th floor, in New York City.
This 2.5-day conference will convene a multidisciplinary group of researchers, clinicians, government and industry representatives, and non-profit leaders to explore the latest scientific advances in the field of addiction, with the end goal of improving treatment. The event will feature sessions and presentations focused on the neural circuitry of addiction, neuroplasticity, the susceptibility of the developing adolescent brain, and new horizons for treatment strategies, and will draw on speakers from the fields of neuroscience, behavioral physiology/medicine, cognitive and clinical neuroimaging, pharmacogenetics, neurobiology, psychology, epigenetics, genetic medicine, criminal justice, policy, and economics.
The conference will conclude with a session dedicated to improving social and government policies so that neuroscience research can be more effectively applied to addiction treatment.
The conference will begin with an evening public lecture and panel discussion, followed by a networking reception. Scientific sessions over the next two days will feature keynote addresses from National Institute on Drug Abuse Director, Nora D. Volkow, MD and National Institute on Alcohol Abuse and Alcoholism Director, George F. Koob, PhD, along with two interactive poster sessions, invited lectures, and short Hot Topic presentations selected from submitted abstracts.
For more information, go to The New York Academy of Sciences website by clicking here.